Interferon-Stimulated Genes and Immune Metabolites as Broad-Spectrum Biomarkers for Viral Infections

Interferon-Stimulated Genes and Immune Metabolites as Broad-Spectrum Biomarkers for Viral Infections

The type I interferon (IFN-I) response is a critical component of the immune defense against various viral pathogens, triggering the expression of hundreds of interferon-stimulated genes (ISGs). These ISGs encode proteins with diverse antiviral functions, targeting various stages of viral replicatio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chien-Hsin Huang, Maudry Laurent-Rolle, Tyler L. Grove, Jack Chun-Chieh Hsu
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Viruses
Subjects:	Biomarker type I Interferon ISGs ddhC MxA ISG15
Online Access:	https://www.mdpi.com/1999-4915/17/1/132
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficiency of interferon stimulated gene 15 expression in peripheral blood for early pregnancy prediction in Awassi ewes
by: Eman H. Lazim, et al.
Published: (2025-01-01)

ISG15 promotes M5-induced hacat cell proliferation through Wnt signaling in psoriasis
by: Sun Xianqi, et al.
Published: (2025-01-01)

Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
by: R. M. Hayes, et al.
Published: (2024-09-01)

The concerted actions of microRNA-29a and interferon-β modulate complete Freund's adjuvant-induced inflammatory pain by regulating the expression of type 1 interferon receptor, interferon-stimulated gene 15, and p-extracellular signal-regulated kinase
by: Chien-Cheng Liu, et al.
Published: (2025-03-01)

A practical guide for choosing an optimal spatial transcriptomics technology from seven major commercially available options
by: Hyun Ju Lim, et al.
Published: (2025-01-01)

The effect of interferon alpha administration on cytokine levels in sheep
by: Devran Coşkun, et al.
Published: (2020-12-01)

Heightened expression of type I interferon signaling genes in CD4+ T cells from acutely HIV-1–infected women is associated with lower viral loads
by: Elina El-Badry, et al.
Published: (2025-01-01)

Diagnostic value of interferon-γ release assay in patients with COPD complicated with pulmonary tuberculosis
by: Yanxiao Rong, et al.
Published: (2025-01-01)

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
by: Kira A Cozzolino, et al.
Published: (2025-02-01)

Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.
by: Leslie Pérez Ruiz, et al.
Published: (2007-12-01)

Divergent Effects of <i>Circoviridae</i> Capsid Proteins on Type I Interferon Signaling
by: Anon H. Kosaka, et al.
Published: (2025-01-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Development of a family-centred core outcome set for infants with developmental dysplasia of the hip treated with a brace
by: Joanna Craven, et al.
Published: (2025-01-01)

HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
by: Jie Zhao, et al.
Published: (2025-02-01)

Regulation of viral replication by host restriction factors
by: Ying Lin, et al.
Published: (2025-01-01)

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
by: Sandra Schwarzlose-Schwarck, et al.
Published: (2025-02-01)

Species- and strain-specific microbial modulation of interferon, innate immunity, and epithelial barrier in 2D air–liquid interface respiratory epithelial cultures
by: Mian Horvath, et al.
Published: (2025-01-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis
by: Loïs Bolko, et al.
Published: (2025-02-01)

NRF2 Antioxidant Response and Interferon‐Stimulated Genes Are Differentially Expressed in SARS‐CoV‐2‐Positive Young Subjects
by: Walter Toscanelli, et al.
Published: (2025-01-01)

The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
by: Na Chen, et al.
Published: (2025-01-01)

Heberferón®’s economic feasibility in patients with high-grade brain tumors without therapeutic options
by: María Margarita Ríos Cabrera, et al.
Published: (2024-07-01)

TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms
by: Nicholas L. Calistri, et al.
Published: (2025-02-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering
by: Ryohei Yamamura, et al.
Published: (2025-02-01)

Cellular aspects of immunity involved in the development of atherosclerosis
by: Khalil Khalaf, et al.
Published: (2025-01-01)

Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes
by: Murali Ganesan, et al.
Published: (2025-01-01)

A modified non-contrast MRI in the preoperative examination of periacetabular osteotomy at 3.0T
by: Chuanhui Xu, et al.
Published: (2025-01-01)

Interferons and Interferon Regulatory Factors in Malaria
by: Sin Yee Gun, et al.
Published: (2014-01-01)

Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers
by: Binhao Liu, et al.
Published: (2025-02-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Pentoxifylline Prevents Autoimmune MediatedInflammation in Low Dose Streptozotocin InducedDiabetes
by: Stanislava D. Sto&#353;i&#263;-Gruji&#269;i&#263;, et al.
Published: (2001-01-01)

COLLECTIONS OF THE WORLD’S CROP GENETIC RESOURCES FOR THE DEVELOPMENT OF PRIORITY PLANT BREEDING TRENDS
by: K. G. Barylnik, et al.
Published: (2018-06-01)

The emerging role of 12/15-lipoxygenase in ischemic stroke
by: Xuening Wang, et al.
Published: (2025-02-01)

Treatment of Chronic Viral Hepatitis with Alpha-Interferon: A Consensus Conference Report
by: The CASL Hepatitis Consensus Group
Published: (1994-01-01)